The duration of follow-up varied across the studies, spanning from 12 to 48 months, with an average follow-up duration of 27.5 months
Appetite Regulation: GLP-1 targets specific areas of the brain that control hunger and the sensation of fullness
[55] Consequently, this lowers the systemic release of inflammatory cytokines like IL-6 and TNF-
GLP-1 hormones, naturally released by your body after eating, help to: Manage insulin levels Increase feelings of fullness Improve insulin sensitivity By mimicking GLP-1 receptors, this allows your bodys own mechanisms to reduce cravings and hunger, helping you feel fuller for longer
SeekPeptides members regularly ask how these two peptides stack up in dosing complexity, and the honest answer is that tirzepatide offers more dose tiers with wider spacing while semaglutide follows a tighter, more incremental escalation pattern
And when you stop taking the drug, keeping the weight off can feel like an uphill, losing battle